chrisvoncsefalvay/vaers-outcomes huggingface dataset:
shortness of breath, heart rate high, dizziness, low blood pressure, dry mouth, feeling faint, weakness, fatigue all over, numbness in feet and hands, two -three weeks of morning anxiety, difficult to operate a car, two tp three weeks stiffness in joints, and  headache.
The morning after the vaccine, sudden onset of severe left-side chest pains, left arm, and back. Persisted till the next day but gradually got better. No pain after 3rd day.; sudden onset of severe left-side chest pains, left arm,; severe left-side chest pains, left arm, and back.; This is a spontaneous report from a contactable consumer or other non-healthcare professional (Patient). A 59-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; Lot Number: EN6202) via an unspecified route of administration (age at vaccination 59-year) in Right Arm on 05Mar2021 15:00 as dose 1, single for COVID-19 immunization. Medical history included Stroke history; early Alzheimers and Diverticulosis from an unknown date and unknown if ongoing. Concomitant medications included Atorvastatin (ATORVASTATIN); aspirin [acetylsalicylic acid] (ASPIRIN [ACETYLSALICYLIC ACID]); Gabapentin (GABAPENTIN); famotidine (PEPCID AC) and Tamsulosin (TAMSULOSIN) taken for an unspecified indication, start and stop date were not reported. The patient was having no known allergies. The patient was not tested COVID prior and post vaccination. It was reported that the patient did not received any other vaccine in four weeks. Facility type vaccine was school or student health clinic. On 06Mar2021 08:30 AM in the morning after the vaccine the patient experienced sudden onset of severe left-side chest pains, left arm, and back. persisted till the next day but gradually got better. no pain after 3rd day. The seriousness of the events was serious (medically significant) and AE resulted in visit emergency room/department or urgent care. Therapeutic measures were taken as a result of the adverse events; AE treatment included: Nitroglycerin, 4 aspirin, lab tests, EKG, X-ray. The clinical outcome of the events was recovered on an unspecified date of Mar2021   No follow-up attempts are possible. No further information is expected.
Patient was not tested for COVID prior to the vaccine; one month after being fully vaccinated, the patient was admitted for pneumonia, altered mental status and reduction in ability to do ADLs. Upon admission, the patient was tested using the Abbott-ID NOW rapid COVID test and patient tested positive on 04/04/2021. Patient clinical presentation consistent with COVID per lung changes on chest x-ray and symptoms, positive for UTI.
Pt. states that after receiving the 2nd dose of Phizer 09/30/2021, started experiencing symptoms 10/02/2021 of Headaches, muscle pain, leg swelling *both lasting 10/09/2021, 10/12/2021 Vein Burst (Ankle) Emergency Room visit,  Primary visit planned for 10/27/2021 for Follow-Up.
No adverse events at this time. The patient received a double dose of the bivalent Pfizer vaccine. She received her first dose on 12/13/22 and second booster dose on 3/15/23.
Blood clot in the brain; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and expiry date were not reported) via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. Medical history included lupus. The patient's concomitant medications were not reported. The patient experienced blood clot in the brain on an unspecified date. It was reported that, consumer stated she had not an adverse reaction. Her sister in law had an adverse reaction, she had lupus and she was not sure if that had caused the blood clot in her brain. She enquired how did she find out if adverse reactions have been reported about this or not. She also enquired had anyone reported the reaction with lupus or lupus cerebritis or not. Cerebritis means that it was affecting the brain. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt recv vax AUG95 & in MAY96 pt devel a rash w/over 100 lesions;
received the adjuvant without the active antigen; received the adjuvant without the active antigen; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 13-JUL-2022 Reporter's Comments: The pharmacist reported that the patient who received the Shingrix adjuvant without the active antigen component.  Lot numbers were unknown.  The reporter had limited information. Additional Supportive Information: The pharmacist reported that the patient received adjuvant portion of Shingrix without the active antigen component, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. This case was linked with US2022AMR106414 and US2022AMR106415, reported by same reporter for different patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR106414:Same case/same reporter US-GLAXOSMITHKLINE-US2022AMR106415:Same case/same reporter
Fever - Mild -  start date 08Jun2021 - end date 08Jun2021 Fatigue - Moderate - start date 07Jun2021 - end date 09Jun2021 Headache - Moderate - start date 08Jun2021 - end date 09Jun2021 Body pain - Mild - start date 08Jun2021 - end date 09Jun2021 Nausea - Severe - start date 08Jun2021 - end date 09Jun2021 Emesis - Mild -start date 08Jun2021 - end date 08Jun2021 Con Med - Tylenol - 325mg
Information has been received from a wholesaler calling on behalf of physician concerning three patients who were each vaccinated SC with a dose of pneumococcal vaccine 23 polyvalent. Subsequently, the patients developed inflammation around the injection site that included redness and soreness. Unspecified medical attention was sought. A product quality complaint was not involved. Follow up information was received from an MD concerning the three pt(s), which included a 89 year old patient, who between 01JUN2003 and 04JUN2003 were each vaccinated SC with a a dose of pneumococcal vaccine 23 polyvalent. Subsequently in approximately June 2003, all three pts developed local swelling, malaise and were not feeling well, "i.e. local reaction". Within three to five days, all three pts had recovered with no residual problems. The reporter noted, "we had 2 more bottles of the same batch, will return". The records of testing prior to release of this lot have been checked by QA and found be to satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. The other two patients included a 68 year old patient and an 69 year old patient. Additional information has been requested..
Received expired vaccine beyond manufacturer date of expiry; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired vaccine beyond manufacturer date of expiry) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 033A21-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 23-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired vaccine beyond manufacturer date of expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired vaccine beyond manufacturer date of expiry) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Patient received full  dose of expired Moderna Vaccine. The vial was initially stored in the refrigerator on 04-MAY-2022. The vial did not undergo any temperature excursions. No treatment details were reported.
the 1st vaccine gave in the left arm, the needle break off from syringe cause the leakage of the medication.  Cannot determine how much injected into the patient. but both pharmacist and the patient don't really feel the vaccine went into the patient. So revaccination was done 30 minutes after the initial failure on the right arm. No sign and symptoms of side effect by the time patient left pharmacy.
Onset of erythematous wheal rash with urticaria. No s/sx of infection. Rash is still present. Pt's mom reports fever. No temp recorded (fever) onsite. Rx for BENADRYL.
mom first noticed welts (underarms, belly, legs) on awakening 3AUG(5 states pt was fussy, irritable last 2 days only checked temp once 2AUG95 AM t101.0 ax; pt seen by RN 3AUG95 appt made @ clinic;
Grand mal seizure w/o fever.Birth wt 4lbs 14 oz, 35 wks gestation.No prior hx of ADR to DTP. No family hx or personal hx of seizures.29Jun90 F/U Questionable ? aseptic menigitis. Pt is fully recovered now.
Fatigue, nausea, dizzyness, headache, difficulty concentrating, generally feeling like I have a concussion
Intermittent pain at site of 2nd injection which started 3 days after shot.  Still continuing now 2 months later at same intensity.  Occurs randomly a few times per week. When pain present causes weakness and  difficulty lifting things.  Can last several hours or just briefly. When pain present it is only with arm movement, no pain when arm still.
Post vax, on approximately 12/04/2000 the patient was exposed to chicken pox at school. Two weeks later on 12/18/2000, the patient developed chicken pox lesions. The chicken pox started off and on at the patient's head, itching back and front. The physician described the patient's chicken pox lesions as "multiple" appearing on his trunk, abdomen, a few on his face, and a few on his arms and extremities. The patient was treated with Calamine Lotion, Benadryl and Advil. No further details were provided. Additional information has been requested.
Nausea, vomiting, diarrhea one day after second moderna vaccination. Found to have hyponatremia and pancytopenia.
3-9-11 About 4 hours of the injection, I started feeling pain between my shoulder and elbow...severe aching which increased as the evening went on. No fever. So about 7 p.m. I took a 1000 mg TYLENOL to ease the pain. (No pinkness at the injection site). It did not help, so I called the hospital for advice and they said to apply ice. Which did not do much. I just hung in there till 11 p.m. so I could take more TYLENOL safely in hopes of taking off the edge so that I could sleep. I was able to sleep through the night after more TYLENOL. During the above time I could not move my arm behind me, I lost range of motion as far as trying to undress myself for bed. (The pain level reminded me of when I had blood poisoning in a finger many many years ago from a rose thorn stick). 3-10-11.. So by morning, the pain level had eased a little bit, but I still could not move my arm enough to independently put on clothes with my left arm, or move it behind my back. 3-11-11 Big improvement with range of motion of my arm, and by then there was a large pink area (very slight swelling) the size of my hand--about 4 inches below the injection point. By the 5th day, all symptoms had subsided.
Rash with hives 1 week after vaccination.  Arm warm and itchy. Patient applied Benadryl cream, but not enough time has passed to determine whether the rash/hives have cleared.
Patient has seizure history. Last seizure was over 1 year ago. Had grand mal seizure 31 hours after receiving flu vaccine.
5 days after receiving PREVNAR shoulder swelled up, got "hot", and was painful. Swelling is approx. 4" x 4".
A patient had a reaction to Prevnar 13/Allergic Reaction; The initial case was missing the following minimum criteria: Unspecified AE. Upon receipt of follow-up information on (25Oct2019), this case now contains all required information to be considered valid.  This is a spontaneous report from a contactable Pharmacist.   A 65-year-old female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13, Batch/lot number: AN85S1 Expiry Date: Nov2021, NDC number: 0005197101) at 0.5mL single dose via intramuscular route on 25Oct2019. The patient had not medical history. The concomitant medications were unknown. On the same date the patient experienced an allergic reaction to the vaccine. The patient got a shot of Benadryl, and she is feeling better. She has multiple comorbidities that warrant her getting the vaccine.  The  event was assessed as serious.
Severe/Explosive diarrhea for 3 days now, extreme GI pain, bloating, swelling,  loss of appetize, fatigue, low back pain and achy all over.  Much more severe then after my 1st Covid shot.
high fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (high fever) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in January 2021.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced PYREXIA (high fever). On 29-Jan-2021, PYREXIA (high fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, COVID-19: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
This spontaneous report as received from a health care worker, also referred to as a C.M.A., also referred to as physician, refers to a female patient of unknown age. On 23-AUG-2012 the patient was vaccinated with RECOMBIVAX HB dose 1, 0.5 ml, intramuscular. Lot number, expiry date and indication were not reported. On 15-APR-2013 the patient was vaccinated with RECOMBIVAX HB dose 2, 0.5 ml, intramuscular, Lot number, expiry date and indication were not reported. On 14-MAY-2012 the patient was scheduled for a vaccination with RECOMBIVAX HB dose 3, 0.5 ml, intramuscular. Lot number, expiry date and indication were not reported. The patient experienced no adverse event. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and ender. In April 2014, the patients were vaccinated with doses of VAQTA (Lot # H019104 exp date 19-JUL-2015) (doses not reported) that were improperly stored. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Approximately 2 weeks after vaccine, I felt like I was short of breath and at nights felt like I was smothering. I went to doctor and received a nuclear stress test, echocardiogram, and blood work and was diagnosed with Diastolic Heart failure with preserved ejection fraction. I was sent to a cardiologist to confirm my diagnosis. I was put on Lasix. I was told the prognosis was not very good. There are different stages and mine is between stage 3 and stage 4.
About 5 hours after my second dose I became very fatigued. I then started experiencing body aches and sweats and chills. My temp was 100.5 before Tylenol. I also experienced GI upset, nausea and diarrhea. The next day after my vaccine I am experiencing a migraine, body aches, a fever of 100.3 and nausea
Extremely sore, swollen, hot to the touch and rash on arm  9-10 days after injection
Pt had a sudden onset of weakness and dizziness after 2nd dose of Moderna Vaccine. Pt was Hypertensive and hyperglycemic. Transported to medical.
Within 1 minute of injection, skin covering entire body became bright red, patient experienced severe low back pain and experienced shortness of breath as well as headache. Episode lasted less than 5 minutes. Localized itching sensation and redness on arm after injection.
Information has been received from an unknown source concerning a 36 year old male who on 30-SEP-2008 was vaccinated intradermally with PNEUMOVAX (lot # not reported) 25mcg/0.5 mL instead of tuberculin purified protein derivative (manufacturer unspecified). Subsequently the patient experienced redness, swelling pain. No further information was available. This is one of two reports from received from the same source. Additional information is not expected.
Abdominal pain, nausea, fatigue, blood in urine.  Seen at doctor and diagnosed with Pancreatitis.
Patient called and stated that he has a rash, swelling and there is heat at the touch from the right shoulder to the elbow area.
Pt developed a rash all around the upper arm, experienced trouble sleeping for 2 nights along with fever and chills.
WHEEZING, CHEST TIGHTNESS, SEVERE CONGESION, BLOODSHOT EYES
PREVENAR 13 given 3/10/11. Pt presented to ER 3/13 with "allergic rash" given BENADRYL, prednisone &  ibuprofen. Seen in office 3/14, 3/15/11 & 3/16/11 with worsening purpura. Seen 3/17 with some clearing - Dx: Vasculitis.
At approx 1050 patient c/o itch while on 30 min observation. Patient states" I have had anaphalaxis before, so I am scared" Patient escorted to private patient assessment area. MD informed. Dr. assessed patient and prescribed Cetirizine 20mg 2 tab to be given PO and monitor for 30 mins. Patient given meds per MD order,  tolerated well.. While on 30 min observation, patient states " my throat feels funny and tight' Dr. Made aware. Dr. assessed patient and ordered 3 puffs of Albuterol to be given to patient. Patient given meds per MD order, tolerated well and monitored for additional 30 mins. Patient states " I feel much better, I can breathe easier". Informed patient that MD will reassess to make sure patient is medically cleared. Patient states " no, I gotta go, thank you. Patient ambulated to exit with steady gait.
RARE CASES OF BLOOD CLOTS AFTER  THE VACCINE ADMINISTRATION; This spontaneous report received from a consumer concerned multiple patients of unspecified race, ethnic origin and age. The patient's weight, height, and medical history were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose,1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced rare cases of blood clots after the vaccine administration. It was reported that reporter knew rare cases where the people had blood clots after administration of Janssen covid-19 vaccine on an unspecified date The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of rare cases of blood clots after the vaccine administration was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210943879-Covid-19 vaccine ad26.cov2.s-Rare cases of blood clots after the vaccine administration . This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
slight numbing of mouth; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6207) via an unspecified route of administration in the left arm on 25Mar2021 at 08:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included allergic to penicillin. Concomitant medications included colecalciferol (VITAMIN D3) from an unknown date and for an unknown indication. Prior to vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 12:00, the patient experienced slight numbing of mouth and fatigue. The patient did not receive any treatment for reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events slight numbing of mouth and fatigue were recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
pt recv vax 27NOV96 & on 13DEC96 pt devel less than 50 lesions on face & chest;
no adverse event reported but patient asked for moderna and we gave patient moderna without realizing patient under 18 years old
This spontaneous report has been received from a nurse referring to a "15-17 years old" patient of unknown gender. Information regarding the patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications was not reported. On an unknown date in March 2018, the patient was vaccinated with GARDASIL 9, by intramuscular route (strength, dose, anatomical location, lot number and expiration date were not provided) for prophylaxis. On the same date, the patient also received "other unknown vaccines". Shortly after, the patient developed a rash on her arm, which lasted two months. The outcome of rash was unknown. The causality assessment between therapy with GARDASIL 9 and the event was not reported.
Tingles, Flush, Blood Pressure initial reading 172/79 at 3:09pm
Same day - extreme arm soreness and burning at vaccine site; 2nd day - whole body aches and pains, vaccine site started swelling, itching and burning, turning red; 3rd day - continued swelling and redness about 2 inches all around vaccine site with dark red at specific vaccine site; this is 6th day since injection, arm is still sore, swollen and red around vaccine site.
Localized pain at first in the left arm deltoid at the injection site; then at 12:00am woke up feeling as if her arm was broke. She describes the pain as stabbing pain that is in the arm at the injection site, radiates down the left side axillary to thoracic region. She also has noted episodes of feeling really hot and then really cold.
Patient C/O left arm pain at site of injection as well as body aches and then felt dizzy. He was assessed and gradually felt better, was able to return to work but then returned again, 20 minutes after leaving to show that he had urticarial lesions on his left forearm. Vs remained stable, rash did not progress and he was sent home with instructions to return  to the ER in the event of progression of symptoms.